Advertisement

Patients: Referral Patterns

  • A. J. Larner
Chapter

Abstract

This chapter examines referral patterns to a dedicated neurology-led cognitive disorders clinic located in a secondary care setting in terms of the numbers of patients seen over the period 2002–2016, referral sources (primary and secondary care), patient characteristics (age, gender, ethnicity, social class, handedness) and casemix in terms of diagnosis. Although referral numbers have increased over the 15-year period, the proportion receiving a diagnosis of dementia has fallen, which may indicate the persistence of a dementia diagnosis gap.

Keywords

Dementia Demographics Diagnosis Referral patterns 

References

  1. Ahmadi-Abhari S, Guzman-Castillo M, Bandosz P, et al. Temporal trend in dementia incidence since 2002 and projections for prevalence in England and Wales to 2040. BMJ. 2017;j2856:358.Google Scholar
  2. Alzheimer’s Society. Dementia UK update. 2nd ed. London: Alzheimer’s Society; 2014.Google Scholar
  3. Association of British Neurologists. Acute neurological emergencies in adults. London: Association of British Neurologists; 2002.Google Scholar
  4. Audit Commission. Forget me not. Developing mental health services for older people in England. London: Audit Commission; 2002.Google Scholar
  5. Bharambe V, Larner AJ. Epidemiology of functional cognitive disorders: a retrospective memory clinic study. Poster P39, Association of British Neurologists Annual Meeting, Birmingham, 9–11 May, 2018.Google Scholar
  6. Blackburn D, Wakefield S, Bell S, Harkness K, Venneri A, Reuber M. Functional memory disorder; review from a memory clinic. J Neurol Neurosurg Psychiatry. 2014;85:e4.CrossRefGoogle Scholar
  7. Borson S, Scanlan J, Brush M, Vitaliano P, Dokmak A. The mini-cog: a cognitive “vital signs” measure for dementia screening in multi-lingual elderly. Int J Geriatr Psychiatry. 2000;15:1021–7.CrossRefPubMedGoogle Scholar
  8. Brodaty H, Pond D, Kemp NM, et al. The GPCOG: a new screening test for dementia designed for general practice. J Am Geriatr Soc. 2002;50:530–4.CrossRefPubMedGoogle Scholar
  9. Brodaty H, Low-Lee F, Gibson L, Burns K. What is the best dementia screening instrument for general practitioners to use? Am J Geriatr Psychiatry. 2006;14:391–400.CrossRefPubMedGoogle Scholar
  10. Brooke P, Bullock R. Validation of a 6 item Cognitive Impairment Test with a view to primary care usage. Int J Geriatr Psychiatry. 1999;14:936–40.CrossRefPubMedPubMedCentralGoogle Scholar
  11. Buschke H, Kuslansky G, Katz M, et al. Screening for dementia with the Memory Impairment Screen. Neurology. 1999;52:231–8.CrossRefPubMedPubMedCentralGoogle Scholar
  12. Cagliarini AM, Price HL, Livemore ST, Larner AJ. Will use of the Six-Item Cognitive Impairment Test help to close the dementia diagnosis gap? Aging Health. 2013;9(6):563.CrossRefGoogle Scholar
  13. Cannon P, Larner AJ. Errors in the scoring and reporting of cognitive screening instruments administered in primary care. Neurodegener Dis Manag. 2016;6:271–6.CrossRefPubMedGoogle Scholar
  14. Copeland JR, McCracken CF, Dewey ME, Wilson KC, Doran M, Gilmore C, Scott A, Larkin BA. Undifferentiated dementia, Alzheimer’s disease and vascular dementia: age- and gender-related incidence in Liverpool. The MRC-ALPHA study. Br J Psychiatry. 1999;175:433–8.CrossRefPubMedPubMedCentralGoogle Scholar
  15. Cordell CB, Borson S, Boustani M, et al. Alzheimer’s Association recommendations for operationalizing the detection of cognitive impairment during the Medicare Annual Wellness Visit in a primary care setting. Alzheimers Dement. 2013;9:141–50.CrossRefPubMedGoogle Scholar
  16. Davies RR, Doran M, Larner AJ. Early-onset dementia. Prog Neurol Psychiatry. 2011;15(4):12–6.CrossRefGoogle Scholar
  17. Department of Health. Living well with dementia: a National Dementia Strategy. London: Department of Health; 2009.Google Scholar
  18. Department of Health. Prime Minister’s challenge on dementia. Delivering major improvements in dementia care and research by 2015. London: Department of Health; 2012.Google Scholar
  19. Department of Health. G8 dementia summit declaration. London: Department of Health; 2013.Google Scholar
  20. Department of Health. Prime Minister’s challenge on dementia 2020. London: Department of Health; 2015.Google Scholar
  21. Department of Health/Alzheimer’s Society. Understanding dementia. A resource pack for GPs and patients. London: Alzheimer’s Society; 2009.Google Scholar
  22. Doran M. Diagnosis of presenile dementia. Br J Hosp Med. 1997;58:105–10.PubMedGoogle Scholar
  23. Fearn S, Larner AJ. Have Quality and Outcomes Framework Depression Indicators changed referrals from primary care to a dedicated memory clinic? Ment Health Fam Med. 2009;6:129–32.Google Scholar
  24. Ferran J, Wilson K, Doran M, Ghadiali E, Johnson F, Cooper P, McCracken C. The early onset dementias: a study of clinical characteristics and service use. Int J Geriatr Psychiatry. 1996;11:863–9.CrossRefGoogle Scholar
  25. Ferri CP, Prince M, Brayne C, et al. Global prevalence of dementia: a Delphi consensus study. Lancet. 2005;366:2112–7.CrossRefPubMedPubMedCentralGoogle Scholar
  26. Fisher CAH, Larner AJ. FAQs: memory loss. Practitioner. 2006;250(1683):14–6, 19, 21.PubMedGoogle Scholar
  27. Fisher CAH, Larner AJ. Frequency and diagnostic utility of cognitive test instrument use by general practitioners prior to memory clinic referral. Fam Pract. 2007;24:495–7.CrossRefPubMedPubMedCentralGoogle Scholar
  28. Folstein MF, Folstein SE, McHugh PR. “Mini-Mental State.” A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189–98.CrossRefPubMedPubMedCentralGoogle Scholar
  29. Gale TM, Larner AJ. Six-Item Cognitive Impairment Test (6CIT). In: Larner AJ, editor. Cognitive screening instruments. A practical approach. 2nd ed. London: Springer; 2017. p. 241–53.CrossRefGoogle Scholar
  30. Ghadiri-Sani M, Larner AJ. Cognitive screening instrument use in primary care: is it changing? Clin Pract. 2014;11:425–9.CrossRefGoogle Scholar
  31. Hodkinson HM. Evaluation of a mental test score for assessment of mental impairment in the elderly. Age Ageing. 1972;1:233–8.CrossRefPubMedGoogle Scholar
  32. Hussey D, Foy K, Meehean K. Quality of dementia referrals to later life psychiatry service. Psychiatr Bull. 2009;33:154–5.CrossRefGoogle Scholar
  33. Kinsey SE, Giles FJ, Holton J. Cusum plotting of temperature charts for assessing antimicrobial treatment in neutropenic patients. BMJ. 1989;299:775–6.CrossRefPubMedPubMedCentralGoogle Scholar
  34. Larner AJ. Two simple questions in the identification of dementia. J Neurol Neurosurg Psychiatry. 2005a;76:1317. (abstract 023)CrossRefGoogle Scholar
  35. Larner AJ. An audit of the Addenbrooke’s Cognitive Examination (ACE) in clinical practice. Int J Geriatr Psychiatry. 2005b;20:593–4.CrossRefPubMedPubMedCentralGoogle Scholar
  36. Larner AJ. Neurologists still have a role in the dementia care pathway. Clin Med. 2007a;7:528–9.CrossRefGoogle Scholar
  37. Larner AJ. DemTect: 1-year experience of a neuropsychological screening test for dementia. Age Ageing. 2007b;36:326–7.CrossRefPubMedPubMedCentralGoogle Scholar
  38. Larner AJ. Addenbrooke’s Cognitive Examination (ACE) for the diagnosis and differential diagnosis of dementia. Clin Neurol Neurosurg. 2007c;109:491–4.CrossRefPubMedPubMedCentralGoogle Scholar
  39. Larner AJ. Neuropsychological neurology: the neurocognitive impairments of neurological disorders. Cambridge: Cambridge University Press; 2008.CrossRefGoogle Scholar
  40. Larner AJ. Impact of the National Institute for Health and Clinical Excellence and Social Care Institute for Excellence’s dementia guidelines in a neurology-led memory clinic. Clin Med. 2009a;9:197–8.CrossRefGoogle Scholar
  41. Larner AJ. Quality of dementia referrals. Psychiatr Bull. 2009b;33:316.CrossRefGoogle Scholar
  42. Larner AJ. ACE-R: cross-sectional and longitudinal use for cognitive assessment. In: Fisher A, Hanin I, editors. New trends in Alzheimer and Parkinson related disorders: ADPD 2009. Collection of selected free papers from the 9th International Conference on Alzheimer’s and Parkinson’s disease AD/PD. Prague, Czech Republic, March 11–15, vol. 2009. Bologna: Medimond International Proceedings; 2009c. p. 103–7.Google Scholar
  43. Larner AJ. Impact of the National Dementia Strategy in a neurology-led memory clinic. Clin Med. 2010;10:526.CrossRefGoogle Scholar
  44. Larner AJ. Teleneurology by internet and telephone. A study in self-help. London: Springer; 2011.CrossRefGoogle Scholar
  45. Larner AJ. Head turning sign: pragmatic utility in clinical diagnosis of cognitive impairment. J Neurol Neurosurg Psychiatry. 2012a;83:852–3.CrossRefPubMedGoogle Scholar
  46. Larner AJ. Screening utility of the Montreal Cognitive Assessment (MoCA): in place of - or as well as - the MMSE? Int Psychogeriatr. 2012b;24:391–6.CrossRefPubMedPubMedCentralGoogle Scholar
  47. Larner AJ. Neuropsychological neurology: the neurocognitive impairments of neurological disorders. 2nd ed. Cambridge: Cambridge University Press; 2013a.CrossRefGoogle Scholar
  48. Larner AJ. Addenbrooke’s Cognitive Examination-Revised (ACE-R): pragmatic study of cross-sectional use for assessment of cognitive complaints of unknown aetiology. Int J Geriatr Psychiatry. 2013b;28:547–8.CrossRefPubMedPubMedCentralGoogle Scholar
  49. Larner AJ. Impact of the National Dementia Strategy in a neurology-led memory clinic: 5-year data. Clin Med. 2014a;14:216.CrossRefGoogle Scholar
  50. Larner AJ. Screening utility of the “attended alone” sign for subjective memory impairment. Alzheimer Dis Assoc Disord. 2014b;28:364–5.CrossRefPubMedGoogle Scholar
  51. Larner AJ. Performance-based cognitive screening instruments: an extended analysis of the time versus accuracy trade-off. Diagnostics (Basel). 2015a;5:504–12.CrossRefGoogle Scholar
  52. Larner AJ. Diagnostic test accuracy studies in dementia. A pragmatic approach. London: Springer; 2015b.Google Scholar
  53. Larner AJ. Mini-Addenbrooke’s Cognitive Examination diagnostic accuracy for dementia: reproducibility study. Int J Geriatr Psychiatry. 2015c;30:1103–4.CrossRefPubMedGoogle Scholar
  54. Larner AJ, editor. Cognitive screening instruments. A practical approach. 2nd ed. London: Springer; 2017.Google Scholar
  55. Larner AJ. Dementia and the health of the nation. In: Severn A, editor. Cognitive changes after surgery. London: Springer; 2018. (in press).Google Scholar
  56. Larner AJ, Coles AJ, Scolding NJ, Barker RA. The A-Z of Neurological Practice. A guide to clinical neurology. 2nd ed. London: Springer; 2011.Google Scholar
  57. Lobo A, Launer LJ, Fratiglioni L, et al. Prevalence of dementia and major subtypes in Europe: a collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology. 2000;54(Suppl5):S4–9.PubMedGoogle Scholar
  58. McManus IC. The history and geography of human handedness. In: Sommer IEC, Kahn RS, editors. Language lateralization and psychosis. Cambridge: Cambridge University Press; 2009. p. 37–58.CrossRefGoogle Scholar
  59. Meeuwsen EJ, Melis RJF, Van Der Aa GCHM, et al. Effectiveness of dementia follow-up care by memory clinics of general practitioners: randomised controlled trial. BMJ. 2012;344:e3086.CrossRefPubMedPubMedCentralGoogle Scholar
  60. Menon R, Larner AJ. Use of cognitive screening instruments in primary care: the impact of national dementia directives (NICE/SCIE, National Dementia Strategy). Fam Pract. 2011;28:272–6.CrossRefPubMedPubMedCentralGoogle Scholar
  61. Milne A, Culverwell A, Guss R, Tuppen J, Whelton R. Screening for dementia in primary care: a review of the use, efficacy and quality of measures. Int Psychogeriatr. 2008;20:911–26.CrossRefPubMedGoogle Scholar
  62. National Institute for Health and Clinical Excellence/Social Care Institute for Excellence. Dementia: supporting people with dementia and their carers in health and social care. NICE clinical guidance 42. London: National Institute for Health and Clinical Excellence; 2006. (www.nice.org.uk/cG042)Google Scholar
  63. O’Connor DW, Pollitt BA, Hyde JB, et al. Do general practitioners miss dementia in elderly patients? BMJ. 1988;297:1107–10.CrossRefPubMedPubMedCentralGoogle Scholar
  64. Price HL, Larner AJ. Type 2 diabetes and cognitive impairment: a case for screening? Prog Neurol Psychiatry. 2013;17(5):6–7.CrossRefGoogle Scholar
  65. Prince M, Wimo A, Guerchet M, et al. World Alzheimer Report 2015. The global impact of dementia. An analysis of prevalence, incidence, cost and trends. London: Alzheimer’s Disease International; 2015.Google Scholar
  66. Rossor MN, Fox NC, Mummery CJ, Schott JM, Warren JD. The diagnosis of young-onset dementia. Lancet Neurol. 2010;9:793–806.CrossRefPubMedPubMedCentralGoogle Scholar
  67. Sackett DL, Haynes RB. The architecture of diagnostic research. BMJ. 2002;324:539–41.CrossRefPubMedPubMedCentralGoogle Scholar
  68. Schoenmaker N, Van Gool WA. The age gap between patients in clinical studies and in the general population: a pitfall for dementia research. Lancet Neurol. 2004;3:627–30.CrossRefPubMedGoogle Scholar
  69. Seeher KM, Brodaty H. The General Practitioner Assessment of Cognition (GPCOG). In: Larner AJ, editor. Cognitive screening instruments. A practical approach. 2nd ed. London: Springer; 2017. p. 231–9.CrossRefGoogle Scholar
  70. Sells R, Larner AJ. The Poppelreuter figure visual perceptual function test for dementia diagnosis. Prog Neurol Psychiatry. 2011;15(2):17–8. 20–1CrossRefGoogle Scholar
  71. Stone J, Pal S, Blackburn D, Reuber M, Thekkumpurath P, Carson A. Functional (psychogenic) cognitive disorders: a perspective from the neurology clinic. J Alzheimers Dis. 2015;48(Suppl1):S5–17.CrossRefPubMedGoogle Scholar
  72. Williamson J, Larner AJ. MACE for diagnosis of dementia and MCI: 3-year pragmatic diagnostic test accuracy study. Dement Geriatr Cogn Disord. 2018;45 (in press).Google Scholar
  73. Wimo A, Prince M. World Alzheimer Report 2010. The global economic impact of dementia. London: Alzheimer’s Disease International; 2010.Google Scholar
  74. Wohl H. The cusum plot: its utility in the analysis of clinical data. N Engl J Med. 1977;296:1044–5.CrossRefPubMedGoogle Scholar
  75. Wojtowicz A, Larner AJ. General Practitioner Assessment of Cognition: use in primary care prior to memory clinic referral. Neurodegener Dis Manag. 2015;5:505–10.CrossRefPubMedGoogle Scholar
  76. Wojtowicz A, Larner A. Scoring errors in cognitive screening instruments administered in primary care. J Neurol Neurosurg Psychiatry. 2016;87:e1.CrossRefGoogle Scholar
  77. Wojtowicz A, Larner AJ. Diagnostic test accuracy of cognitive screeners in older people. Prog Neurol Psychiatry. 2017;21(1):17–21.CrossRefGoogle Scholar
  78. World Health Organization. Dementia: a public health priority. Geneva: World Health Organization; 2012.Google Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • A. J. Larner
    • 1
  1. 1.Cognitive Function ClinicWalton Centre for Neurology and NeurosurgeryLiverpoolUK

Personalised recommendations